Evidence map›Paper›PMID 34632357›Full record

ArticleJournal of translational autoimmunity2021

Programmed cell death-1

Nikolaos K Gatselis, Kalliopi Azariadis, Aggeliki Lyberopoulou, George N Dalekos

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of translational autoimmunity, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.4field-weighted citation impact, top 40% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nikolaos K GatselisDepartment of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110, Larissa, Greece.
Kalliopi AzariadisDepartment of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110, Larissa, Greece.
Aggeliki LyberopoulouDepartment of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110, Larissa, Greece.
George N DalekosDepartment of Medicine and Research Laboratory of Internal Medicine, National Expertise Center of Greece in Autoimmune Liver Diseases, General University Hospital of Larissa, 41110, Larissa, Greece.
University Hospital of Larissa · GR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAutoimmune hepatitis (AIH) is a relatively rare chronic liver disease of unknown etiology. The genetic background affects susceptibility, clinical phenotype, and prognosis. The

aimOur aim was to investigate for the first time the incidence and clinical significance of

methodsTwo hundred patients with AIH were evaluated, while 100 healthy subjects were used as controls. Genotyping was performed with

resultsThe SNP

conclusionsThe

Indexed as

AIH, Autoimmune hepatitis.ANA, Antinuclear antibodies.Anti-LC1, Liver cytosol type-1 antibodies.Anti-LKM1, Liver kidney microsomal type-1 antibodiesAnti-SLA/LP, Soluble liver antigen/liver pancreas antibodies.Autoimmune hepatitisCR, Complete response.HCC, Hepatocellular carcinoma.HCV, Hepatis C virus.HDL, High density lipoprotein.HLA, Human leukocyte antigen.HWE, Hardy-weinberg equilibrium.IgG, Immunoglobulin class G.IL28B, Interleukin 28B.INR, International normalized ratio.Interleukin-28BIQR, Interquartile range.LDL, Low density lipoproteinMetS, Metabolic syndrome.NAFLD, Non-alcoholic fatty liver disease.PCR, Polymerase chain reaction.PD1, Programmed cell death-1.PolymorphismsProgrammed cell death-1SD, Standard deviation.SLE, Systemic lupus erythematosus.SMA, Smooth muscle antibodies.SNP, Single nucleotide polymorphism.ULN, Upper limit of normal.

Identifiers

PMID34632357
PMCPMC8488593
OpenAlexW3204753524

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.